Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted route for high-purity triazole synthesis, offering significant cost reduction and scalable manufacturing for global API supply chains.
Novel palladacycle catalyst enables high-yield aryl nitrile synthesis using safe potassium ferrocyanide, offering cost-effective pharma intermediate solutions.
Patent CN118878452B enables high-yield synthesis under mild conditions with significant cost savings for reliable pharmaceutical intermediate supply chains.
Novel Pt/C-catalyzed method enables scalable production of high-purity pharmaceutical intermediates with simplified purification and substantial cost reduction potential.
Patent CN108148021B enables one-step carbene insertion synthesis of high-purity furan derivatives with mild conditions and scalable production for pharmaceutical intermediates.
Solve N-aryl imine allylation challenges with this metal-free, air-tolerant process. Achieve 94% yields and eliminate expensive anhydrous equipment. Contact for CDMO scale-up.
Eliminate palladium catalysts and complex steps in alkynyl imine synthesis. Our one-pot method reduces costs, ensures high purity, and accelerates heterocyclic compound production for pharma R&D.
Solve nitrile synthesis challenges with this novel metal-free route. Achieve 78% yield, no toxic byproducts, and scalable production for anti-inflammatory drug development.
Solve C-N bond construction challenges in heterocyclic synthesis with room-temperature amination. 90% yield, easy scale-up for API manufacturing.
Discover a novel synthesis method for indole-derived piperidines with >95% diastereoselectivity and 76% yield. Ideal for pharmaceutical R&D and cost-effective production of anti-cancer agents.
Eliminate NaN3 hazards in fluorinated compound synthesis. Our CDMO expertise ensures scalable, high-yield production for your pharmaceutical intermediates.
Discover a metal-free, air-tolerant synthesis for trifluoroacetimide dihydrobenzofuran compounds. Eliminate heavy metal catalysts and nitrogen protection to reduce costs and improve supply chain reliability for pharmaceutical intermediates.